2004
DOI: 10.1016/j.resuscitation.2004.01.016
|View full text |Cite
|
Sign up to set email alerts
|

A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
41
0
8

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(49 citation statements)
references
References 12 publications
0
41
0
8
Order By: Relevance
“…[187][188][189][190][191][192][193][194] Despite the potential to increase the risk of severe bleeding, fibrinolytics may improve survival to discharge and long-term neurological function in patients with presumed PE-induced cardiac arrest. [193][194][195][196] Emergency echocardiography may be helpful in determining the presence of thrombus or PE.…”
Section: Acls Modificationsmentioning
confidence: 99%
“…[187][188][189][190][191][192][193][194] Despite the potential to increase the risk of severe bleeding, fibrinolytics may improve survival to discharge and long-term neurological function in patients with presumed PE-induced cardiac arrest. [193][194][195][196] Emergency echocardiography may be helpful in determining the presence of thrombus or PE.…”
Section: Acls Modificationsmentioning
confidence: 99%
“…244,245 One study showed an increased risk of intracranial bleeding associated with the routine use of fibrinolytics during cardiac arrest (LOE 1). 245 Seven studies showed benefit from fibrinolytic therapy in the treatment of victims of cardiopulmonary arrest unresponsive to standard therapy; however, those studies had significant limitations (LOE 1 246 ; LOE 2 [247][248][249][250] ; LOE 3 251,252 ).…”
Section: Consensus On Sciencementioning
confidence: 99%
“…245 One meta-analysis of 8 retrospective cohort studies with a variety of causes of cardiac arrest (pulmonary embolism, 2 studies; myocardial infarctions, 4 studies; cardiology diseases, 1 study; and nontraumatic etiologies, 1 study) demonstrated an increased rate of ROSC, survival to discharge, and long-term neurological function with fibrinolytic, but it also showed an increased risk of severe bleeding (LOE 2). 719 Nine studies of patients with presumed pulmonary embolism or all patients with cardiopulmonary arrests showed improvement with fibrinolysis in ROSC and admission to the hospital or ICU, but no improvement in survival to discharge (LOE 1 246 ; LOE 2 248,250 ; LOE 3 251 ; LOE 4 247,720 -723 ). Three studies showed good neurological function in those who survived after successful fibrinolysis during CPR (LOE 2 719 ; LOE 3 722 ; LOE 4 721 ).…”
Section: Consensus On Sciencementioning
confidence: 99%
“…Early prospective controlled trials associated this technique with a low rate of complications. [29][30][31][32][33] However, subsequent larger trials have revealed no such benefit. 33,34 As a result, the current American Heart Association guidelines report no convincing evidence that the routine use of thrombolytic agents during resuscitation improves survival rates.…”
Section: Discussionmentioning
confidence: 99%